Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Depreciation and Depletion (2017 - 2025)

Catheter Precision (VTAK) has disclosed Depreciation and Depletion for 9 consecutive years, with $17000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion fell 10.53% to $17000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $75000.0, a 47.06% increase, with the full-year FY2024 number at $65000.0, up 103.12% from a year prior.
  • Depreciation and Depletion was $17000.0 for Q3 2025 at Catheter Precision, down from $18000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $400000.0 in Q1 2021 to a low of -$21000.0 in Q4 2022.
  • A 5-year average of $83833.3 and a median of $18500.0 in 2024 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: plummeted 107.0% in 2022, then surged 233.33% in 2024.
  • Catheter Precision's Depreciation and Depletion stood at $300000.0 in 2021, then tumbled by 107.0% to -$21000.0 in 2022, then soared by 128.57% to $6000.0 in 2023, then soared by 233.33% to $20000.0 in 2024, then fell by 15.0% to $17000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Depreciation and Depletion are $17000.0 (Q3 2025), $18000.0 (Q2 2025), and $20000.0 (Q1 2025).